University of Birmingham: New study to test third COVID-19 vaccine for people with weakened immune systems

The study, OCTAVE DUO, will offer people who are immunosuppressed or immunocompromised a Pfizer, Moderna or Novavax vaccine to determine whether this will give a stronger immune response than two doses.The £2.2 million study will build on the OCTAVE

Related Keywords

United Kingdom ,Sajid Javid ,Pam Kearns ,Iain Mcinnes ,Pfizer ,United Kingdom Research ,Scientist Of The Medical Research Council ,Committee On Vaccination ,Life Sciences ,University Of Birmingham ,University Of Glasgow ,Cancer Research United Kingdom Clinical Trials ,Associated Vasculitis ,Vaccines Taskforce ,Joint Committee ,Social Care Secretary Sajid Javid ,Rob Buckle ,Chief Scientist ,Medical Research Council ,